Description: MAX Automation SE, together with its subsidiaries, provides automation solutions for the automotive, electrical, recycling, raw materials recycling, packaging, and medical technology industries in Germany, rest of the European Union, North America, China, and internationally. The bdtronic Group segment develops, produces, and sells machines and systems with integrated software solutions for high precision manufacturing processes for the automotive, electronics and medical technology industries. The Vecoplan Group segment develops, produces, and installs machines and plants for the shredding, conveying, and processing of raw materials for customers in wood and recycling, waste disposal, and paper and plastics industries. The MA micro Group segment focuses on the development, manufacture, and distribution of production, assembly and testing systems for medical and optical components such as lenses, lasers, and camera modules, as well as for medical products such as contact lenses, Tip&Cup, stents, or insulin pens. The AIM Micro segment develops, produces, and distributes technologies for the manufacture of optoelectronic modules and micro-optical components for customers in the medical technology and sensor industry as well as the aerospace industry. The iNDAT segment develops, manufactures, integrates, and maintains industrial robots, as well as robot controllers. The NSM + Juecker segment provides automation solutions and customised solutions. The Elwema segment develops and manufactures solution in testing, assembly, and cleaning technology for automotive industry, especially for the engine, transmission, and steering sectors. The company was formerly known as MAX Automation AG and changed its name to MAX Automation SE in February 2018. MAX Automation SE was incorporated in 1991 and is headquartered in Dusseldorf, Germany.
Home Page: www.maxautomation.com
Breite Strasse 29-31
Düsseldorf,
40213
Germany
Phone:
49 211 9099 10
Officers
| Name | Title |
|---|---|
| Dr. Christian Diekmann | Chairman of Management Board, CEO & MD |
| Dr. Ralf Guckert | MD & COO |
| Mr. Hartmut Buscher | CFO, MD & Supervisory Board Member |
| Katja Redweik | Head of Corp. Devel. & Investor Relations |
| Mr. Daniel Fink | Advisor |
Exchange: XETRA
Country: DE
Currency: Euro (€)
| Forward PE: | 18.9753 |
|---|---|
| Trailing PE: | 16.4 |
| Price-to-Book MRQ: | 2.3185 |
| Price-to-Sales TTM: | 0.6453 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1595 |